C entral venous catheters (CVCs) are commonly used in the management of critically ill patients. An estimated five million CVCs are inserted annually in the United States (1) . Catheter-related bloodstream infections (CRBSIs) have been reported to occur in 3-8% of catheters inserted and are the predominant cause of nosocomial bacteremia in intensive care units (ICUs), with 80,000 cases annually at a cost of US$300 million to US$2.3 billion (1) (2) (3) (4) . The additional financial cost may be as high as US$30,000 per survivor, including one extra week in ICU and 2-3 additional weeks in hospital (5, 6) . Estimates of attributable mortality between 10% and 35% remain controversial (1, 6) .
The role of antimicrobial catheters in the prevention of CRBSI remains uncer-tain despite comprehensive evidencebased guidelines (2, (7) (8) (9) . Many of the published trials comparing coated with uncoated catheters have been limited by their size and methodology (8, 10) . However, Maki et al. (11) found that catheters coated with chlorhexidine-silver sulfadiazine (CSSD) on their external surface (Arrowgard Blue, Arrow International, Reading, PA) reduced colonization and CRBSI. A subsequent meta-analysis supported a significant decrease in CRBSI when CSSD catheters were compared with uncoated catheters (12) .
Another antimicrobial catheter has rifampicin and minocycline (RM) coating on both the external and internal surfaces (Spectrum, Cook Critical Care, Bloomington, IN) (13) . The developers reported the RM catheter to be one third as likely as the CSSD catheter to be colonized and one tenth as likely to be the cause of CRBSI (14) .
More recently, microscopic particles of silver, platinum, and carbon (SPC) Objective: Central venous catheters are the predominant cause of nosocomial bacteremia; however, the effectiveness of different antimicrobial central venous catheters remains uncertain. We compared the infection rate of silver-platinum-carbon (SPC)-impregnated catheters with rifampicin-minocycline (RM)-coated catheters.
Design: A large, single-center, prospective randomized study. Setting: Twenty-two-bed adult general intensive care unit in a large tertiary metropolitan hospital in Brisbane, Australia (2000 -2001) .
Patients: Consecutive series of all central venous catheterizations in intensive care unit patients.
Interventions: Randomization, concealment, and blinding were carefully performed. Catheter insertion and care were performed according to published guidelines. Blood cultures were taken at central venous catheter removal, and catheter-tip cultures were performed by both roll-plate and sonication techniques. Pulsed field gel electrophoresis was used to establish shared clonal origin for matched isolates.
Measurements and Main Results: Central venous catheter colonization and catheter-related bloodstream infection were deter-mined with a blinded technique using the evaluation of the extensive microbiological and clinical data collected and a rigor- have been combined with polyurethane to manufacture a catheter with silver ions continuously available to external and internal surfaces through "iontophoresis" (Vantex, Edwards Lifesciences, Irvine, CA). The electrical conductivity of carbon particles facilitates a redox reaction between silver and platinum particles to produce a sustained release of silver ions (2, 15) . The bactericidal effect of the silver ions occurs through reactions with thiol groups in cell-membrane related enzymes, blocking oxidative phosphorylation, and binding to the DNA helix in organisms (15) . The efficacy of the SPC catheter has been demonstrated by in vitro studies (16, 17) and variably supported by smaller clinical studies and a meta-analysis (2, 18 -20) . There are no previous studies comparing SPC catheters with either CSSD or RM catheter types.
The primary aim of the study was to compare the rates of colonization between SPC and RM CVCs in a high-risk population of intensive care patients, with CRBSI as a secondary end point. We have attempted to address some of the methodological issues of many previous studies with a rigorous protocol, careful definitions, and extensive clinical and microbiological data collection.
METHODS
Patients and Setting. This study was conducted in the Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Queensland, Australia (April 2000 to September 2001) with 22 beds admitting 1,400 medical and surgical adult patients annually. All patients requiring insertion of a CVC while in the ICU were eligible. Exclusion criteria were allergies to the constituent antimicrobials.
Ethical Considerations. The institutional Ethics Committee approved the protocol and waived the requirement for individual patient consent. Both catheter types were approved by the Australian Therapeutic Goods Administration and were in use in the ICU. CVCs were inserted and removed according to usual clinical indications. Standard insertion and line care techniques were followed using previously implemented guidelines (21) . The study did not involve any additional procedures or testing, and the required clinical and microbiological data were already being routinely collected.
Randomization and Blinding. Blocks of ten computer-generated random numbers were used. Burn patients were randomized in blocks of six, given their higher risk and smaller numbers. The randomly sequenced CVC sets in identical individual opaque covers were placed in a sealed dispenser box, which allowed removal of only the lowest CVC in the stack. The set was drawn from the box after the decision to insert a CVC for an individual patient and was brought to the bedside still in its opaque cover. No other triple-lumen catheters were available for the duration of the trial. Staff inserting and caring for the CVC could not be blinded due to the different colors of the two catheter types; however, all other aspects of the study were blinded and concealed. Culture results were reported by laboratory staff unaware of the catheter type. Clinical and microbiological data were collected, assessed, and analyzed by research staff without knowledge of the catheter type or any role in catheter insertion or care.
Catheter Insertion, Care, and Removal. All CVCs were inserted by trained ICU medical staff, with no guide-wire exchanges and no tunneling, following skin preparation with 0.5% chlorhexidine in 70% alcohol and with full sterile technique and barrier precautions, including wide area drapes. The subclavian vein was the preferred site, followed by the internal jugular and then femoral veins. Transparent semipermeable polyurethane dressings (Opsite IV 3000, Smith & Nephew, UK) were changed weekly with aseptic technique, or if indicated by soiling or degrada- (9) Colonized catheter: growth of Ն15 colony-forming units (semiquantitative culture) or Ͼ10 3 (quantitative culture) from a proximal or distal catheter segment in the absence of clinical symptoms. Catheter-related bloodstream infection (CRBSI): isolation of the same organism (i.e., identical species, antibiogram) from a semiquantitative or quantitative culture of a catheter segment and from the blood (preferably drawn from a peripheral vein) of a patient with accompanying clinical symptoms of bloodstream infection and no other apparent source of infection. In the absence of laboratory confirmation, defervescence after removal of an implicated catheter from a patient with bloodstream infection may be considered indirect evidence of CRBSI. CDC Clinical Definition for CRBSI (2002) (21) Bacteremia/fungemia in a patient with an intravascular catheter with at least one positive blood culture obtained from a peripheral vein, clinical manifestations of infections (i.e., fever, chills, and/or hypotension), and no apparent source of bloodstream infection except the catheter. One of the following should be present: a positive semiquantitative (Ͼ15 colony-forming units/catheter segment) or quantitative (Ͼ10 3 tion. Fluid bags were replaced daily and administration sets every 7 days (22) . CVCs were removed if a new systemic inflammatory response syndrome (SIRS) ( Table 1) or bacteremia occurred and the CVC was judged to be a likely site of infection, or if the CVC was no longer required. Removal by aseptic technique included site preparation with chlorhexidine 0.5% in 70% alcohol, which was then allowed to dry, following which the catheter was removed and the distal 4-cm catheter tip was sent for culture. Twenty milliliters of blood was drawn, by peripheral venipuncture or during the insertion of a new CVC, and 10 mL inoculated into each of two BacT/Alert FA (Biomerieux, Durham, NC) blood culture bottles.
Microbiological Testing. CVC tips were cultured by both the Maki roll plate and Sherertz sonication techniques (23, 24) . Colonization was established by either or both techniques giving a positive result ( Table 1) . All isolates were identified to species level. Antimicrobial resistances were determined by standard NCCLS techniques. Isolates associated with CRBSI were batched for pulsed field gel electrophoresis (Chef system, GenePath reagents, BioRad Laboratories, Hercules, CA) to ensure that they shared the same clonal origin with the relevant blood culture isolate.
Additional Data Collection. We collected patient age, gender, Acute Physiology and Chronic Health Evaluation (APACHE) II score, APACHE III diagnostic category, and APACHE II and III comorbidities. The operators recorded in the clinical information system their seniority, the type of CVC, insertion site, number of passes, mechanical complications, and recognized breaches of sterile technique. Subsequent use of high-risk infusions (parenteral nutrition, lipid emulsions, propofol, or blood products) was noted. Positive peripheral blood cultures on the day of CVC removal or 2 days either side were considered potential CRBSI. For those patients with positive blood or catheter-tip cultures, we collated all microbiology from other sites, including twice weekly surveillance cultures for multiply resistant organisms (urine, tracheal aspirates, rectal swab, wounds), for 7 days either side of the day of CVC removal. The highest and lowest of each SIRS variable was collated for the day of CVC removal and for the 2 days either side.
Outcome Definitions. We expanded the full Centers for Disease Control (CDC) definitions for CRBSI into a classification for catheterrelated bacteremia (CRB) (Tables 1 and 2) (9, 10, 21). CDC definitions for catheter-related infection were also amended to remove requirements for accompanying clinical symptoms or defervescence (21) . An intensivist (DF) made the diagnosis and classification of colonization and CRBSI from coded data sheets that did not reveal the catheter type, and all data were entered before breaking the code.
Statistical Analysis. A baseline colonization rate of 14% for CSSD catheters was determined by a recently conducted 6-month audit. Power analysis estimated that 300 CVCs were required in each arm of the study to detect a 50% relative reduction in colonization rates with 80% statistical power (␤ ϭ .2, ␣ ϭ .05).
Analysis was conducted with Stata software (version 8.2, Statacorp, College Station, TX). All categorical data, including the primary and secondary outcomes, were compared using Fisher's exact test. Continuous data were compared using Student's t-test. Times to catheter-related infection for catheters remaining in situ were compared using the exact logrank test on the Kaplan-Meier estimates. In addition to a per-protocol approach, where only evaluable catheter tips were analyzed, we performed an intention-to-treat analysis on the primary outcome, which regarded all nonevaluable catheter tips as not colonized. Significance values were based on two-tailed tests with p Ͻ .05 considered significant.
RESULTS
There were 646 CVCs inserted over the study period, 319 RM catheters and 327 SPC catheters, of which 89% were microbiologically evaluable. Appropriately timed blood cultures were available in 73% of the total, or 82% and 83% of evaluable RM and SPC catheters, respectively ( Fig. 1 ). There were no significant differences in the baseline characteristics between the two groups ( Table 3) .
Specialist intensivists and intensive care medicine trainees inserted 49% of CVCs, and 81% of CVCs were inserted on the first or second pass (Table 3 ). Insertion complications were more frequent for the RM catheter type, principally due to failed insertions as the catheters tended to "stick" in the insertion tract, although this did not achieve significance (9.1% vs. 6.1%, p ϭ .181). Seventy-five percent of insertions were subclavian placements.
The time in situ for each catheter type was similar (SPC 149.4 hrs, RM 149.9 hrs). Ninety-two percent (595 of 645) of CVC removals occurred during an episode of SIRS, and 28% were associated with subsequent defervescence (155 of 560; postremoval SIRS data nonevaluable in 86 [43 due to death]).
Colonization rates were significantly lower for the RM catheters than SPC catheters (RM 25 of 280, 8.9%; SPC 43 of 294, 14.6%; p ϭ .039) ( Table 4 ). A similar level of significance (p ϭ .030) was achieved on an intention-to-treat analysis.
The Kaplan-Meier analysis used both catheter time in situ and time to colonization (Fig. 2) . The difference in colonization rates between the CVC types just failed to meet significance (p ϭ .055).
CRBSI that was classified as "definite catheter-related bacteremia" (definite CRB) occurred in low numbers for each catheter type (RM 4, 1.4%; SPC 5, 1.7% "possible CRB" were also infrequent ( Table 4 ), and if all categories of CRB were aggregated there were 20 episodes (7.1%) for RM catheters and 28 episodes (9.5%) for SPC catheters (p ϭ .366).
Fourteen (4.8%) SPC catheters were colonized with two or more organisms-12 with two organisms, and one each with three and four organisms. Three (1.1%) RM catheters were colonized with two different organisms ( Table 5 ).
DISCUSSION
We have performed the largest singlecenter, prospective, randomized study comparing the effects of two antimicrobial technologies on catheter-related infections. The study demonstrated a lower colonization rate for the RM catheter than the SPC catheter (8.9% vs. 14.6%, p ϭ .039), which then just failed to reach statistical significance on Kaplan-Meier analysis incorporating CVC time in situ (p ϭ .055) (Fig. 2) . In combination, this is moderate evidence of a true differ-ence between the catheter types. There was no difference between the low rates of CRBSI for both catheter types (RM 1.4%, SPC 1.7%).
The catheter-related infection rates reported here are in keeping with the previous literature and support a clinically significant antimicrobial action for the SPC catheter. Our colonization rate for the SPC catheter (14.6%) is similar to that found by Maki et al. (11) for the CSSD catheter (13.5%), whereas our colonization rate for the RM catheter (8.9%) is similar to rates for the RM catheter reported by Raad (14) for the RM catheter (0.3%) and the CSSD catheter (3.4%).
The recent literature continues to question the role and choice of antimicrobial catheters in preventing CRBSI and calls for additional and more rigorous studies (2, 7-10, 12, 25-27) . This study was carefully designed and conducted on the basis of a critical examination of the literature and with a previously published classification system to increase the rigor of the CRBSI diagnosis (10) . We directly compared the SPC and RM catheter types, as a third study group of nonantimicrobial control catheters would have required a prohibitive increase in sample size. The study was appropriately powered, based on the ICU's previous colonization rates, to provide a meaningful result from the comparison for catheter colonization. A study to detect a 50% reduction in CRBSI (80% power, ␣ ϭ .05) would require more than 3,000 CVCs in each study arm, calculated on the basis of these and previous results.
Colonization may be regarded as a suitable surrogate marker for CRBSI. This has been supported by an analysis that reviewed all published studies and found a good correlation between cathe- ter-tip colonization and CRBSI (r ϭ .69, p Ͻ .001) (28) . Interestingly, the authors commented that one reason for the lessthan-perfect correlation was the differing study definitions of CRBSI. Colonization may also be more suitable than CRBSI as a clinical performance measure because of its more frequent occurrence and clear definition and because catheter-tip culture is easily performed on a routine basis at minimal cost.
Our sample was a complete sequence of exclusively intensive care patients. This ensures that our study population is representative of an acknowledged highrisk group, although this may restrict the broader applicability of our results to non-ICU patients. A novel feature of our protocol was the requirement for routine blood cultures at the time of CVC removal to reduce the potential for bias being introduced by clinical operators not blinded to catheter type (14, 20) or using clinical judgment as an indication for blood cultures (11, 13, 14, 20) .
CVC insertion by skilled experienced operators (49%) and placement in the lowest infection-risk subclavian site (75%) compare favorably with other studies, and mean CVC duration in situ was almost identical (11, 13, 14, 20) . A high proportion of study catheter-tips were able to be microbiologically evaluated (89%), and the majority of our exclusions were due to catheter dislodgment or death (Fig. 1) . We accounted for all catheters inserted (Fig. 1) and also performed an intention-to-treat analysis.
The RM catheter has previously been reported as a major advance over the CSSD catheter (2, 14, 26, 29 -33) . This was variously attributed to the choice of antimicrobial agents (29, 34) , the agents being applied to both external and inter- nal surfaces (7, 14) , and the duration of activity of the coating (35) (36) (37) . However, the significance of the lower colonization rate of the RM catheter (7.9%) in Darouiche et al.'s study (14) was partly reliant on a strikingly high colonization rate for the CSSD catheter (23%). This was in fact similar to the rates for nonantimicrobial control catheters in studies by Maki et al. (11) (24%) and Raad et al. (13) and Darouiche et al. (14) (26%). In addition, a recent study compared RM catheters with nonantimicrobial catheters and found a decrease in colonization rates (RM 10%, noncoated 24%) but no significant decrease in CRBSI with the RM catheter (RM 3.1%, noncoated 5.9%) (38) . There continue to be concerns regarding the risk of antibi-otic resistance occurring among organisms with low-dose long-term exposure to antibiotics (7, 39 -41) .
Our results do show a modest decrease in the colonization rate with the use of the RM catheter in comparison to the SPC catheter. There is limited information on the sustainability of silver ion release from the SPC catheter, and our results may reflect a more favorable duration of activity of the RM catheter (16) . There is good evidence that RM catheters continue to elute antibacterial activity for up to 14 days postinsertion (36, 37) . However, such levels may not correlate with in vivo efficacy, as catheter biofilm reduces antibiotic penetration, bacterial vulnerability, and antibiotic uptake and increases plasmid transfer (42) . Furthermore, the elution of antibiotics from coated catheters into culture media may interfere with the detection of colonization and, in common with other studies, neutralizing agents were not used in the culture media.
Both RM and ionic silver catheters are expected to have a wide range of antimicrobial activity on the basis of in vitro studies (16, 17, 34, 43, 44) . Initial adherence of Gram-positive organisms, particularly slime-producing coagulase-negative staphylococci, is better prevented by the RM catheters, whereas the SPC catheters are more effective at preventing adherence of Gram-negative organisms (16, 43, 45, 46) . In our study there were larger numbers of both Gram-positive and Gram-negative organisms colonizing the SPC catheter tips (Table 5 ). However, the higher rate of colonization of RM catheters by Candida species observed here is consistent with the results of the previous clinical studies of this catheter type (13, 14, 37, 38) .
A recent review of 11 randomized studies found that all used different definitions of CRBSI (8) . The most commonly used CDC definitions include a requirement for clinical criteria, although they are rather poorly defined (Table 1) (9, 10, 21, 28, 47) . Despite this requirement, Veenstra et al. (12) noted that of the 13 studies suitable for evaluation from a total of 215 found on Medline, only one reported on clinical symptoms.
To address this issue we previously developed a more detailed classification system for the CDC clinical definitions for CRB and colonization (Tables 1 and 2) and have also suggested abandoning the requirement for clinical features to be present or absent for the diagnosis of CRBSI or colonization, respectively, at least for critically ill and immunosuppressed patients (10) . In this study we prospectively collected relevant clinical data and found rates of SIRS before CVC removal (92%) and of defervescence following CVC removal (28%) that far exceeded the occurrence of any form of catheter-related infection. We used pulsed field gel electrophoresis to confirm the same clonal identity of the isolated organisms from blood and catheter-tip cultures for all the episodes of CRB, in contrast to some other major studies (13, 18 -20, 38, 48) . Meticulous attention to other possible sources of bacteremia also allowed us to identify nine episodes in which the organism found on the catheter tip and blood culture was also colonizing another site, which were therefore classified as possible CRB type 1 ( Table 4 ). Although the inclusion of these or even all "possible" CRB episodes would not have altered our results (Table 5) , the same may not be true for previous studies. Inadequate microbiological surveillance of other potential sources of infection or the use of clinical criteria to substitute for missing microbiological data may overestimate the incidence of CRBSI.
We therefore recommend that only the criteria for "definite CRB" be regarded as diagnostic of CRBSI for future research. CRBSI would then comprise a positive blood culture (up to 48 hrs either side of CVC removal), a positive cathetertip culture for the same organism (confirmed by molecular biological techniques), and the absence of the same organism either colonizing or infecting other sites including routine surveillance cultures. Clinical features of infection would not be required for the diagnosis. This degree of stringency would markedly increase the reliability of diagnosis and classification and improve the comparability of results both within and between studies.
CONCLUSIONS
This study was conducted to compare the colonization rate of SPC-impregnated CVCs with RM-coated catheters. The SPC catheter is a clinically effective antimicrobial catheter. The RM catheter demonstrated a lower colonization rate. There was no difference in the rates of CRBSI. The methodology used in this study may help develop improved standards for further investigations of antimicrobial catheters, which are likely to require many thousands of catheters. 
